Company intelligence / Profile preview

Advanced Oncotherapy

Ownership: Private
Employees: ~60
Development stage: Commercial

Overview

Advanced Oncotherapy has developed the LIGHT proton therapy system, which offers more precise and cost-effective cancer radiotherapy compared to traditional cyclotron-based systems. Simulation studies suggest superior organ preservation in breast cancer treatment versus legacy technologies. The first high-energy beam milestone was achieved; integration with clinical equipment and regulatory approvals are ongoing. Clinical use pending final approvals and installations at pilot sites such as SUNY Upstate Medical Center.

Therapeutic areas: OncologyOther
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Thales Group (industrialization/manufacturing partnership)

Beyond the preview

Go deeper on Advanced Oncotherapy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Oncotherapy.

Explore the full profile